Brief: NextCell Pharma: Promising Results From Stem Cell Study With ProTrans

NextCell Pharma AB

04/12/2019 11:05

Dec 4 (Reuters) - NextCell Pharma AB  NXTCL.TE :
    * PROMISING RESULTS FROM STEM CELL STUDY WITH PROTRANS
    * ANNOUNCES TODAY THAT PRIMARY EFFICACY MEASURES HAVE
REACHED
SIGNIFICANCE IN DOSE-ESCALATION PHASE OF COMPANY'S CLINICAL
TRIAL
    * NO SERIOUS SIDE EFFECTS HAVE BEEN REPORTED

Source text for Eikon:  ID:nWkr3N52ff 
Further company coverage:  NXTCL.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))